Related Experiment Video
Updated: May 29, 2026
04:39
A Neonatal Rodent Model of Retroorbital Vein Injection
Published on: February 23, 2024
Pharmacological research in neonatology
Andrea Dotta1, Annabella Braguglia, Guglielmo Salvatori
1Neonatal Intensive and Subintensive Care Unit and Department of Medical and Surgical Neonatology, Bambino Gesù Children's Hospital, Rome, Italy. ndrea.dotta@opbg.net
Summary
Neonatal drug use is often off-label, necessitating specialized research. Designing pediatric drug trials requires careful consideration of pharmacokinetics, trial design, and ethical implications for newborns.
Area of Science:
- Neonatal pharmacology
- Pediatric drug development
Background:
- High prevalence of off-label drug use in neonatal units, especially Neonatal Intensive Care Units (NICUs).
- Neonates exhibit unique physiological characteristics affecting drug absorption, distribution, metabolism, and elimination compared to older populations.
Purpose of the Study:
- To highlight the critical need for age-specific pharmacological research in neonates.
- To outline essential considerations for designing effective and ethical neonatal drug trials.
Main Methods:
- Emphasizes defining pediatric diseases by natural history, prevalence, severity, and treatment impact.
- Advocates for adapted methodologies like pharmacokinetics, moving beyond adult-dose corrections.
- Promotes the use of Randomized Controlled Trials (RCTs) over observational studies and discourages small trials.
Main Results:
- Identifies significant differences in neonatal pharmacokinetics necessitating tailored approaches.
- Stresses the importance of robust trial designs to ensure drug efficacy and safety in neonates.
Conclusions:
- Neonatal drug research requires specialized methodologies and ethical considerations.
- Future pediatric drug trials must incorporate pharmacokinetic data and robust designs to improve outcomes for neonates.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...